Page last updated: 2024-12-06

2-nitro-9-fluorenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-nitro-9-fluorenone: RN given refers to cpd with nitro moiety in position 2 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID18356
SCHEMBL ID229511
MeSH IDM0138040

Synonyms (36)

Synonym
9h-fluoren-9-one, 2-nitro-
2-nitro-9-fluorenone
AG-690/32513034
2-nitro-9h-fluoren-9-one
ccris 2540
brn 2052959
nsc 12365
nsc12365
nsc-12365
3096-52-4
OPREA1_378233
2-nitro-9-fluorenone, 99%
inchi=1/c13h7no3/c15-13-11-4-2-1-3-9(11)10-6-5-8(14(16)17)7-12(10)13/h1-7h
2-nitrofluoren-9-one
ajeahbzzhsliqp-uhfffaoysa-
N0202
2-nitrofluorenone
4-07-00-01636 (beilstein handbook reference)
2sc85737ss ,
unii-2sc85737ss
AKOS015998136
STL282771
AKOS015912900
SCHEMBL229511
2-nitro-9h-fluoren-9-one #
9-fluorenone, 2-nitro
AJEAHBZZHSLIQP-UHFFFAOYSA-N
DTXSID70184942
mfcd00001152
AS-58790
J-018205
Q63391635
FT-0743726
CCG-314846
2-nitrofluorenon
CS-0313590
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (42.86)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.21 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]